Implications of the PEGASUS-TIMI 54 trial for US clinical practice

OBJECTIVES: This study aims to determine the proportion of real-world patients with myocardial infarction (MI) who would have been eligible for the PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Steven M, Hess, Gregory P, Stewart, Patrick, Armstrong, Ehrin J, Farmer, Steven A, Wasfy, Jason H, Valle, Javier Alfonso, Sandhu, Amneet, Maddox, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Heart 2017
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471865/
https://www.ncbi.nlm.nih.gov/pubmed/28674626
http://dx.doi.org/10.1136/openhrt-2016-000580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471865/
https://www.ncbi.nlm.nih.gov/pubmed/28674626
http://dx.doi.org/10.1136/openhrt-2016-000580

Ejemplares similares